Quality of Life Research

, Volume 22, Issue 6, pp 1353–1360 | Cite as

Type D, anxiety and depression in association with quality of life in patients with Parkinson’s disease and patients with multiple sclerosis

  • Tatiana Dubayova
  • Martina Krokavcova
  • Iveta Nagyova
  • Jaroslav Rosenberger
  • Zuzana Gdovinova
  • Berrie Middel
  • Johan W. Groothoff
  • Jitse P. van Dijk



The present study examines the role of Type D personality, anxiety and depression in quality of life (QoL) in patients with two chronic neurological diseases—Parkinson’s disease (PD) and multiple sclerosis (MS).


This cross-sectional study included 142 PD patients (73 % males; mean age 67.6 ± 9.2 years) and 198 patients with MS (32.3 % males; 38.4 ± 10.8 years). Multiple regression analyses were used to analyze the association of UDPRS (PD patients) or EDSS (MS patients), Type D personality (DS-14) and anxiety and depression (HADS) with the physical (PCS) and mental summary (MCS) of QoL, as measured by the SF-36.


In PD patients, Type D was significantly associated with MCS only; in MS patients, Type D was significantly associated with both dimensions—MCS and PCS. After adding anxiety and depression, the importance of Type D for the QoL model dramatically decreased. Anxiety and depression were strongly associated with lower scores in MCS and PCS in both PD and MS patients.


The actual mood of PD and MS patients—the level of anxiety or depression—might have a greater impact on patients’ QoL than their personality. Further longitudinal research should focus on how the pathway consisting of personality traits, anxiety and depression, and QoL might be constructed.


Parkinson’s disease Multiple sclerosis Quality of life Type D personality Depression Anxiety 



This work was supported by the Slovak Research and Development Agency under contract No. APVV-20-038305 (20 %) and APVV-0220-10 (60 %). Furthermore, this work was partially supported by the Agency of the Slovak Ministry of the Education, Science, Research and Sport of the Slovak Republic for the Structural Funds of the EU under project No. ITMS: 26220120058 (20 %).


  1. 1.
    Roth, J., Sekyrova, M., & Ruzicka, E. (1999). Parkinsonova nemoc [Parkinson’s disease] (2nd ed.). Praha: Maxdorf.Google Scholar
  2. 2.
    Simons, G., Thompson, S. B., & Smith-Pasqualini, M. C. (2006). An innovative education program for people with Parkinson’s disease and their carers. Parkinsonism and Related Disorders, 12(8), 478–485.PubMedCrossRefGoogle Scholar
  3. 3.
    European Commission. (2004). Some elements on the situation of multiple sclerosis in the European Union, 2004. Access January 3, 2012.
  4. 4.
    McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, P.-H., Lublin, F. D., et al. (2001). Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Annals of Neurology, 50(1), 121–127.PubMedCrossRefGoogle Scholar
  5. 5.
    Bashir, K., & Whitaker, J. N. (2002). Handbook of multiple sclerosis. Philadelphia: Lipinncott Williams and Wilkins.Google Scholar
  6. 6.
    Damiano, A. M., Snyder, C., Strausser, B., & Willian, M. K. (1999). A review of health-related quality of life concepts and measures for Parkinson’s disease. Quality of Life Research, 8(3), 235–243.PubMedCrossRefGoogle Scholar
  7. 7.
    Schrag, A., Jahanshahi, M., & Quinn, N. (2000). How does Parkinson’s disease affects quality of life? A comparison with quality of life in general population. Movement Disorders, 15(6), 1112–1118.PubMedCrossRefGoogle Scholar
  8. 8.
    Benito-Leon, J., Morales, J. M., Rivera-Navarro, J., & Mitchell, A. J. (2003). A review about the impact of multiple sclerosis on health-related quality of life. Disability and Rehabilitation, 25(23), 1291–1303.PubMedCrossRefGoogle Scholar
  9. 9.
    Mitchell, A. J., Benito-Leon, J., Gonzalez, J. M., & Rivera-Navarro, J. (2005). Quality of life and its assessment in multiple sclerosis: Integrating physical and psychological components of well-being. Lancet Neurology, 4(9), 556–566.PubMedCrossRefGoogle Scholar
  10. 10.
    Riazi, A., Hobart, J. C., Lamping, D. L., Fitzpatrick, R., Freeman, J. A., Jenkinson, C., et al. (2003). Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson’s disease with normal population health profiles. Journal of Neurology, Neurosurgery and Psychiatry, 74(6), 710–714.PubMedCrossRefGoogle Scholar
  11. 11.
    Slaughter, J. R., Slaughter, K. A., Nichols, D., Holmes, S. E., & Martens, M. P. (2001). Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson’s disease. Journal of Neuropsychiatry and Clinical Neurosciences, 13(2), 187–196.PubMedCrossRefGoogle Scholar
  12. 12.
    Schrag, A. (2006). Quality of life and depression in Parkinson’s disease. Journal of the Neurological Sciences, 248(1–2), 151–157.PubMedCrossRefGoogle Scholar
  13. 13.
    Siegert, R. J., & Abernethy, D. A. (2005). Depression in multiple sclerosis: A review. Journal of Neurology, Neurosurgery and Psychiatry, 76(4), 469–475.PubMedCrossRefGoogle Scholar
  14. 14.
    Chwastiak, L., Ehde, D. M., Gibbons, L. E., Sullivan, M., Bowen, J. D., & Kraft, G. H. (2002). Depressive symptoms and severity of illness in multiple sclerosis: Epidemiological study of a large community sample. American Journal of Psychiatry, 159(11), 1862–1868.PubMedCrossRefGoogle Scholar
  15. 15.
    Brown, R. F., Valpiani, E. M., Tennant, C. C., Dunn, S. M., Sharrock, M., Hodgkinson, S., et al. (2009). Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis. Psychology and Psychotherapy, 82(1), 41–56.PubMedCrossRefGoogle Scholar
  16. 16.
    Coffey, C. E., & Cummings, J. L. (1994). Parkinson’s disease and parkinsonism. In C. E. Coffey & J. L. Cummings (Eds.), Textbook of geriatric neuropsychiatry (pp. 434–456). Washington DC: American Psychiatric Press.Google Scholar
  17. 17.
    Goretti, B., Portaccio, E., Zipoli, V., Hakiki, B., Siracusa, G., Sorbi, S., et al. (2009). Coping strategies, psychological variables and their relationship with quality of life in multiple sclerosis. Neurological Sciences, 30(1), 15–20.PubMedCrossRefGoogle Scholar
  18. 18.
    Montel, S., Bonnet, A.-M., & Bungener, C. (2009). Quality of life in relation to mood, coping strategies, and dyskinesia in Parkinson’s disease. Journal of Geriatric Psychiatry and Neurology, 22(2), 95–102.PubMedCrossRefGoogle Scholar
  19. 19.
    Larsen, R. J. (1992). Neuroticism and selective encoding and recall of symptoms: Evidence from a combined concurrent-retrospective study. Journal of Personality and Social Psychology, 62(3), 480–488.PubMedCrossRefGoogle Scholar
  20. 20.
    Kempen, G. I. J. M., Jelicic, M., & Ormel, J. (1997). Personality, chronic medical morbidity, and health-related quality of life among older persons. Health Psychology, 16(6), 539–546.PubMedCrossRefGoogle Scholar
  21. 21.
    Jelicic, M., Kempen, G. I., & Passchier, J. (1998). Psychological well-being in older adults suffering from chronic headache. Headache, 38(4), 292–294.PubMedCrossRefGoogle Scholar
  22. 22.
    Ranchor, A. V., Sanderman, R., & Steptoe, A. (2002). Pre-morbid predictors of psychological adjustment to cancer. Quality of Life Research, 11(2), 101–113.PubMedCrossRefGoogle Scholar
  23. 23.
    Ramirez-Maestre, C., Martinez, A. E. L., & Zarazaga, R. E. (2004). Personality characteristics as differential variables of the pain experience. Journal of Behavioral Medicine, 27(2), 147–165.PubMedCrossRefGoogle Scholar
  24. 24.
    Kidachi, R., Kikuchi, A., Nishizawa, Y., Hiruma, T., & Kaneko, S. (2007). Personality types and coping style in hemodialysis patients. Psychiatry and Clinical Neurosciences, 61(4), 339–347.PubMedCrossRefGoogle Scholar
  25. 25.
    van Straten, A., Cuijpers, P., van Zuuren, F. J., Smits, N., & Donker, M. (2007). Personality traits and health-related quality of life in patients with mood and anxiety disorders. Quality of Life Research, 16(1), 1–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Dubayova, T., Nagyova, I., Havlikova, E., Rosenberger, J., Gdovinova, Z., Middel, B., et al. (2009). Neuroticism and extraversion in association with quality of life in patients with Parkinson’s disease. Quality of Life Research, 18(1), 33–42.PubMedCrossRefGoogle Scholar
  27. 27.
    Pedersen, S. S., & Denollet, J. (2004). Validity of the Type D personality construct in Danish post-MI patients and healthy controls. Journal of Psychosomatic Research, 57(3), 265–572.PubMedCrossRefGoogle Scholar
  28. 28.
    Denollet, J. (2005). DS-14: Standard assessment of negative affectivity, social inhibition and Type D personality. Psychosomatic Medicine, 67(1), 89–97.PubMedCrossRefGoogle Scholar
  29. 29.
    Denollet, J., Sys, S. U., Stroobant, N., Rombouts, H., Gillebert, T. C., & Brutsaert, D. L. (1996). Personality as independent predictor of long-term mortality in patients with coronary heart disease. Lancet, 347(8999), 417–421.PubMedCrossRefGoogle Scholar
  30. 30.
    Kupper, N., & Denollet, J. (2007). Type D personality as a prognostic factor in heart disease: Assessment and mediating mechanisms. Journal of Personality Assessment, 89(3), 265–276.PubMedCrossRefGoogle Scholar
  31. 31.
    Mols, F., & Denollet, J. (2009). Type D personality among nonvascular patient populations: A systematic review. General Hospital Psychiatry, 32(1), 66–72.PubMedCrossRefGoogle Scholar
  32. 32.
    Dubayova, T., Nagyova, I., Havlikova, E., Rosenberger, J., Gdovinova, Z., & Middel, B., et al. (2009b). The association of Type D personality with quality of life in patients with Parkinson’s disease. Aging and Mental Health, 13(6), 905–912Google Scholar
  33. 33.
    Bartels, H., Pedersen, S. S., van der Laan, B. F. A. M., Staal, M. J., Albers, F. W. J., & Middel, B. (2010). The impact of Type D personality on health-related quality of life in tinnitus patients is mainly mediated by anxiety and depression. Otology and Neurotology, 31(1), 11–18.PubMedCrossRefGoogle Scholar
  34. 34.
    Emons, W. H. M., Meijer, R. R., & Denollet, J. (2007). Negative affectivity and social inhibition in cardiovascular disease: Evaluating Type D personality and its assessment using item response theory. Journal of Psychosomatic Research, 63(1), 27–39.PubMedCrossRefGoogle Scholar
  35. 35.
    Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992). Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: A clinico-pathological study of 100 cases. Journal of Neurology, Neurosurgery and Psychiatry, 55(3), 181–184.PubMedCrossRefGoogle Scholar
  36. 36.
    Folstein, M. F., Folstein, S. E., & McHough, P. R. (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal Psychiatric Research, 12(3), 189–198.Google Scholar
  37. 37.
    van Hilten, J. J., van der Zwan, A. D., Zwinderman, A. H., & Ross, R. A. (1994). Rating impairment and disability in Parkinson’s disease: Evaluation of the unified Parkinson’s disease rating scale. Movement Disorders, 9(1), 84–88.PubMedCrossRefGoogle Scholar
  38. 38.
    Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology, 33(11), 1444–1452.PubMedCrossRefGoogle Scholar
  39. 39.
    Zigmond, S., & Snaith, R. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361–370.PubMedCrossRefGoogle Scholar
  40. 40.
    Ware, J., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). Medical Care, 30(6), 473–483.PubMedCrossRefGoogle Scholar
  41. 41.
    Ware, J. E., Snow, K. K., Kosinski, M., & Gandek, M. (1993). SF-36 health survey: Manual and interpretation guide. Boston: New England Medical Center.Google Scholar
  42. 42.
    Newcombe, R. G., & Altman, D. G. (2000). Proportions and their differences. In D. G. Altman, D. Machin, & T. N. Bryant (Eds.), Statistic with confidence. London: BMJ Books.Google Scholar
  43. 43.
    Horstink, M., Tolosa, E., Bonuccelli, U., Deuschl, G., Friedman, A., & Kanovsky, P., et al. (2006a). European Federation of Neurological Societies; Movement Disorder Society-European Section. Review of the therapeutic management of Parkinson’s disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson’s disease. European Journal of Neurology, 13(11), 1170–1185Google Scholar
  44. 44.
    Horstink, M., Tolosa, E., Bonuccelli, U., Deuschl, G., Friedman, A., & Kanovsky, P., et al. (2006b). (2006). European Federation of Neurological Societies; Movement Disorder Society-European Section. Review of the therapeutic management of Parkinson’s disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: Late (complicated) Parkinson’s disease. European Journal of Neurology, 13(11), 1186–1202Google Scholar
  45. 45.
    Vidal, A., Gomez-Gil, E., Sans, M., Portella, M. J., Salamero, M., Pique, J. M., et al. (2008). Health-related quality of life in inflammatory bowel disease patients: The role of psychopathology and personality. Inflammatory Bowel Diseases, 14(7), 977–983.PubMedCrossRefGoogle Scholar
  46. 46.
    Allison, P. J., Locker, D., & Feine, J. S. (1997). Quality of life: A dynamic construct. Social Science and Medicine, 45(2), 221–230.PubMedCrossRefGoogle Scholar
  47. 47.
    Hyland, M. E. (1992). A reformulation of quality of life for medical science. Quality of Life Research, 1(4), 267–272.PubMedCrossRefGoogle Scholar
  48. 48.
    Buenaver, L. F., Edwards, R. R., Smith, M. T., Gramling, S. E., & Haythornthwaite, J. A. (2008). Catastrophizing and pain-coping in young adults: Associations with depressive symptoms and headache pain. The Journal of Pain, 9(4), 311–319.PubMedCrossRefGoogle Scholar
  49. 49.
    Wahl, A., Hanestad, B. R., Wiklund, I., & Moum, T. (1999). Coping and quality of life in patients with psoriasis. Quality of Life Research, 8(5), 427–433.PubMedCrossRefGoogle Scholar
  50. 50.
    Hesselink, A. E., Penninx, B. W., Schlösser, M. A., Wijnhoven, H. A. H., van der Windt, D. A. W. M., Kriegsman, D. M. W., et al. (2004). The role of coping resources and coping style in quality of life of patients with asthma or COPD. Quality of Life Research, 13(2), 509–518.PubMedCrossRefGoogle Scholar
  51. 51.
    Folkman, S., & Lazarus, R. S. (1988). Centrality and individual differences in the meaning of daily hassles. Journal of Personality, 56(4), 743–762.PubMedCrossRefGoogle Scholar
  52. 52.
    Ratsep, T., Kallasmaa, T., Pulver, A., & Gross-Paju, K. (2000). Personality as a predictor of coping efforts in patients with multiple sclerosis. Multiple Sclerosis, 6(6), 397–402.PubMedGoogle Scholar
  53. 53.
    Havlikova, E., Rosenberger, J., Nagyova, I., Middel, B., Dubayova, T., Gdovinova, Z., et al. (2008). Impact of fatigue on quality of life in patients with Parkinson’s disease. European Journal of Neurology, 15(5), 475–480.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  • Tatiana Dubayova
    • 1
    • 2
    • 6
  • Martina Krokavcova
    • 1
    • 3
  • Iveta Nagyova
    • 1
    • 3
  • Jaroslav Rosenberger
    • 1
  • Zuzana Gdovinova
    • 4
  • Berrie Middel
    • 5
  • Johan W. Groothoff
    • 5
  • Jitse P. van Dijk
    • 1
    • 5
  1. 1.Kosice Institute for Society and HealthP.J. Safarik UniversityKosiceSlovakia
  2. 2.Department of Special Education, Faculty of PedagogyUniversity of PresovPresovSlovakia
  3. 3.Department of Social Medicine, Faculty of Medicine, Institute of Public HealthP.J. Safarik UniversityKosiceSlovakia
  4. 4.Department of Neurology, Faculty of MedicineP.J. Safarik UniversityKosiceSlovakia
  5. 5.Department of Social Medicine, University Medical Center GroningenUniversity of GroningenGroningenThe Netherlands
  6. 6.Department of Special Education, Faculty of EducationUniversity of PresovPresovSlovakia

Personalised recommendations